216 related articles for article (PubMed ID: 17170749)
41. Endocytosis targets exogenous material selectively to cathepsin S in live human dendritic cells, while cell-penetrating peptides mediate nonselective transport to cysteine cathepsins.
Reich M; van Swieten PF; Sommandas V; Kraus M; Fischer R; Weber E; Kalbacher H; Overkleeft HS; Driessen C
J Leukoc Biol; 2007 Apr; 81(4):990-1001. PubMed ID: 17261546
[TBL] [Abstract][Full Text] [Related]
42. Development of small molecule inhibitors and probes of human SUMO deconjugating proteases.
Albrow VE; Ponder EL; Fasci D; Békés M; Deu E; Salvesen GS; Bogyo M
Chem Biol; 2011 Jun; 18(6):722-32. PubMed ID: 21700208
[TBL] [Abstract][Full Text] [Related]
43. Evolutionary lines of cysteine peptidases.
Barrett AJ; Rawlings ND
Biol Chem; 2001 May; 382(5):727-33. PubMed ID: 11517925
[TBL] [Abstract][Full Text] [Related]
44. Activity-based profiling of proteases.
Sanman LE; Bogyo M
Annu Rev Biochem; 2014; 83():249-73. PubMed ID: 24905783
[TBL] [Abstract][Full Text] [Related]
45. Cloning and expression of the cathepsin F-like cysteine protease gene in Escherichia coli and its characterization.
Joo HS; Koo KB; Park KI; Bae SH; Yun JW; Chang CS; Choi JW
J Microbiol; 2007 Apr; 45(2):158-67. PubMed ID: 17483802
[TBL] [Abstract][Full Text] [Related]
46. Structural and biochemical studies on procaspase-8: new insights on initiator caspase activation.
Keller N; Mares J; Zerbe O; Grütter MG
Structure; 2009 Mar; 17(3):438-48. PubMed ID: 19278658
[TBL] [Abstract][Full Text] [Related]
47. Serine protease inhibitors N-alpha-tosyl-L-lysinyl-chloromethylketone (TLCK) and N-tosyl-L-phenylalaninyl-chloromethylketone (TPCK) are potent inhibitors of activated caspase proteases.
Frydrych I; Mlejnek P
J Cell Biochem; 2008 Apr; 103(5):1646-56. PubMed ID: 17879947
[TBL] [Abstract][Full Text] [Related]
48. In Vitro Use of Peptide Based Substrates and Inhibitors of Apoptotic Caspases.
McStay GP
Methods Mol Biol; 2016; 1419():57-67. PubMed ID: 27108431
[TBL] [Abstract][Full Text] [Related]
49. Selective detection and inhibition of active caspase-3 in cells with optimized peptides.
Vickers CJ; González-Páez GE; Wolan DW
J Am Chem Soc; 2013 Aug; 135(34):12869-76. PubMed ID: 23915420
[TBL] [Abstract][Full Text] [Related]
50. Activity-based fingerprinting and inhibitor discovery of cysteine proteases in a microarray.
Uttamchandani M; Liu K; Panicker RC; Yao SQ
Chem Commun (Camb); 2007 Apr; (15):1518-20. PubMed ID: 17406693
[TBL] [Abstract][Full Text] [Related]
51. A novel photoaffinity-based probe for selective detection of cathepsin L active form.
Torkar A; Bregant S; Devel L; Novinec M; Lenarčič B; Lah T; Dive V
Chembiochem; 2012 Nov; 13(17):2616-21. PubMed ID: 23125066
[TBL] [Abstract][Full Text] [Related]
52. Site-selective and nondestructive protein labeling through azaelectrocyclization-induced cascade reactions.
Tanaka K; Fujii Y; Fukase K
Chembiochem; 2008 Oct; 9(15):2392-7. PubMed ID: 18821553
[No Abstract] [Full Text] [Related]
53. Caspases: determination of their activities in apoptotic cells.
Vaculova A; Zhivotovsky B
Methods Enzymol; 2008; 442():157-81. PubMed ID: 18662569
[TBL] [Abstract][Full Text] [Related]
54. A selective activity-based probe for the papain family cysteine protease dipeptidyl peptidase I/cathepsin C.
Yuan F; Verhelst SH; Blum G; Coussens LM; Bogyo M
J Am Chem Soc; 2006 May; 128(17):5616-7. PubMed ID: 16637611
[TBL] [Abstract][Full Text] [Related]
55. Synthesis, antiviral activity, and conformational studies of a P3 aza-peptide analog of a potent macrocyclic tripeptide HCV protease inhibitor.
Randolph JT; Zhang X; Huang PP; Klein LL; Kurtz KA; Konstantinidis AK; He W; Kati WM; Kempf DJ
Bioorg Med Chem Lett; 2008 Apr; 18(8):2745-50. PubMed ID: 18375121
[TBL] [Abstract][Full Text] [Related]
56. Design, synthesis, and evaluation of in vivo potency and selectivity of epoxysuccinyl-based inhibitors of papain-family cysteine proteases.
Sadaghiani AM; Verhelst SH; Gocheva V; Hill K; Majerova E; Stinson S; Joyce JA; Bogyo M
Chem Biol; 2007 May; 14(5):499-511. PubMed ID: 17524981
[TBL] [Abstract][Full Text] [Related]
57. Design, synthesis, and evaluation of gamma-phosphono diester analogues of glutamate as highly potent inhibitors and active site probes of gamma-glutamyl transpeptidase.
Han L; Hiratake J; Kamiyama A; Sakata K
Biochemistry; 2007 Feb; 46(5):1432-47. PubMed ID: 17260973
[TBL] [Abstract][Full Text] [Related]
58. Structure-guided design of substituted aza-benzimidazoles as potent hypoxia inducible factor-1alpha prolyl hydroxylase-2 inhibitors.
Frohn M; Viswanadhan V; Pickrell AJ; Golden JE; Muller KM; Bürli RW; Biddlecome G; Yoder SC; Rogers N; Dao JH; Hungate R; Allen JR
Bioorg Med Chem Lett; 2008 Sep; 18(18):5023-6. PubMed ID: 18755588
[TBL] [Abstract][Full Text] [Related]
59. Solid-phase synthesis of peptide vinyl sulfones as potential inhibitors and activity-based probes of cysteine proteases.
Wang G; Mahesh U; Chen GY; Yao SQ
Org Lett; 2003 Mar; 5(5):737-40. PubMed ID: 12605503
[TBL] [Abstract][Full Text] [Related]
60. Properties of the caspases.
Stennicke HR; Salvesen GS
Biochim Biophys Acta; 1998 Sep; 1387(1-2):17-31. PubMed ID: 9748481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]